Factors Associated with Outcomes of Percutaneous Transluminal Renal Angioplasty in Patients with Renal Artery Stenosis: A Retrospective Analysis of 50 Consecutive Cases

Abstract EN

Background.

The results of recent trials have brought some confusion to the treatment strategy for renal artery stenosis (RAS).

To evaluate the applicability of percutaneous transluminal renal angioplasty (PTRA) for RAS, we extracted the factors that may affect the effectiveness of PTRA from cases experienced at a hypertension center.

Methods and Results.

We retrospectively assessed the blood pressure (BP) lowering effects and renoprotective effects in 50 consecutive patients that had hemodynamically significant RAS and had undergone PTRA and stenting during 2001–2005.

Subjects were diagnosed with atherosclerotic RAS (42), fibromuscular dysplasia (6), or Takayasu disease (2).

After PTRA, BP significantly lowered from 152.3/80.3 mmHg to 132.6/73.2 mmHg (p<0.05), but the estimated glomerular filtration rate (eGFR) did not change significantly.

There were no factors associated with the BP lowering effects of PTRA.

The baseline resistive index (RI) was negatively correlated with the change in eGFR (p<0.05).

After correction for age, sex, BMI, and the dose of contrast medium, the association of RI with change in eGFR remained significant.

Conclusion.

In cases with hemodynamically significant RAS, PTRA lowered BP but was not effective in improving renal function.

Higher baseline RI may be a factor for predicting poor clinical course of renal function after PTRA.